Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

This study is observing how pathologists (doctors who examine tissue samples) use artificial intelligence tools in their daily work when diagnosing lung and breast cancer. It does not involve any new treatment — researchers are simply watching how AI assists with analyzing tissue slides. **You may be eligible if...** - You are 18 years or older - You have a tissue sample taken because lung cancer (non-small cell type) or breast cancer (invasive or early-stage ductal) is suspected **You may NOT be eligible if...** - Your tissue slide is of poor technical quality (e.g., broken, blurry, or improperly preserved) - Your tissue sample was used in previous training or testing of the AI system - Your sample was collected using fine needle aspiration (a thin needle to extract cells) - Your sample was sent for cytology (fluid or loose cell analysis rather than a solid tissue biopsy) Talk to your doctor to see if this trial is right for you.